Sign In
Buy HUM
$349.89
+22.35 (+6.82%)
At Close: Jun 04, 2026
AHF Files $27M Arbitration Claim Against Humana Over Pharmacy Fees
02:52pm, Thursday, 19'th Sep 2024
LOS ANGELES--(BUSINESS WIRE)--AHF Files $27M Arbitration Claim Against Humana Over Pharmacy Fees.
Texas A&M University Mays Business School and Humana Launch Annual Nationwide Healthcare Analytics Case Competition
11:00am, Thursday, 19'th Sep 2024
COLLEGE STATION, Texas--(BUSINESS WIRE)--Texas A&M University Mays Business School and Humana launch annual nationwide healthcare analytics case competition.
Humana Earns 2024 Great Place To Work Certification
10:10am, Thursday, 19'th Sep 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--For the third consecutive year, Humana Inc., a leading health and well-being company, is named a Certified™ Great Place To Work®. The prestigious award is based en
5 Incredible Healthcare High-Yield Blue-Chip Bargain Buys For 2025
07:00am, Thursday, 19'th Sep 2024
Healthcare is undervalued despite being the top sector for earnings growth, making it an attractive investment with solid fundamentals and the potential for explosive returns in 2025. Investing in hea
Humana's Falling Share Price Gives Investors An Opportunity
10:37pm, Tuesday, 17'th Sep 2024
Humana has slid 10% due to exiting 13 markets, raising investor concerns, but remains attractive due to strong profitability and management alignment with investor interests. Despite trailing the S&P
Humana (HUM), Evergreen Nephrology Partner to Improve Health Outcomes
02:50pm, Friday, 30'th Aug 2024
HUM collaborates with Evergreen Nephrology to introduce a specialized care program for chronic kidney disease patients.
Why Is Humana (HUM) Down 2.1% Since Last Earnings Report?
12:37pm, Friday, 30'th Aug 2024
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Humana and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease
10:05am, Thursday, 29'th Aug 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana and Evergreen Nephrology introduce new specialized care program for patients living with kidney disease.
$50 To $70 In Less Than A Year: Is Johnson Controls Stock Headed To $80 Next?
08:00am, Wednesday, 28'th Aug 2024
Johnson Controls stock (NYSE: HUM) currently trades around $70 per share, compared to its peak levels of over $80 seen in January 2022. While the company's stock has shed more than 10% of its value, C
Can Humana Stock Return To $500 From Its Current Level Of $350?
05:00am, Tuesday, 27'th Aug 2024
Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over the
Humana Inc. to Present at 2024 Wells Fargo Healthcare Conference
04:15pm, Monday, 19'th Aug 2024
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at the Wells Fargo Healthcare Conference
Seth Klarman's Baupost Group cuts stake in Alphabet and snaps up Humana
05:45am, Wednesday, 14'th Aug 2024
Seth Klarman's hedge fund, Baupost Group, cut its position in Google-owner Alphabet in the second-quarter of 2024 while also snapping up a stake in health insurance company Humana, new 13-f filings sh
The Schall Law Firm Urges Shareholders Who Sustained Losses With Humana Inc To Initiate Dialogue
05:45pm, Tuesday, 06'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Co
NEW YORK, Aug. 04, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Humana Inc. (NYSE: HUM) on behal
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Humana Inc. – HUM
10:57am, Saturday, 03'rd Aug 2024
NEW YORK, Aug. 03, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Humana Inc. (“Humana” or the “Company”) (NYSE: HUM). Such investors
